BALAXI PHARMACEUTICALS LIMITED — Board Meeting, 30-05-2025: Outcome of Board Meeting

Balaxi Pharmaceuticals has announced a board meeting on May 30, 2025, approving the financial results for the quarter and year ended March 31, 2025. The company posted consolidated revenue of Rs 202.56 Cr and a net profit of Rs 25.07 Cr, indicating solid operational strength. The board re-appointed M/s Siva Ramakrishna & Associates as internal auditors and brought in M/s BVR & Associates as secretarial auditors for five years (pending shareholder approval). Their first formulation plant at Jadcherla is progressing well, with machinery installed and validation expected by end-June. The 82nd AGM will be held on August 25 via video conference.